Explore the evolving landscape of clinical trials in drug discovery and learn about recent breakthroughs transforming the ...

A Phase I trial involving ten patients with relapsed or refractory classical Hodgkin lymphoma or T-cell lymphoma has achieved a 100% overall response rate and a 50% complete remission rate, in ...

Researchers from the Sant Pau Research Institute (IR Sant Pau), in collaboration with Sant Pau Hospital and the Josep ...

Patient recruitment remains a significant challenge for biopharma companies, often leading to delays and increased costs in clinical trials ... pre-screening tasks to complete before moving ...

and ongoing communication with patients and caregivers to answer any questions that arise. 3. Optimise clinical research stipend management: Expedite completed visit confirmation and extend timely ...

ATH434–202: Open-label, Biomarker Phase 2 Clinical Trial in Advanced MSA On 27 March 2025, Alterity announced that the last patient in the ATH434-202 Phase 2 trial completed the study.

Johnson & Johnson (J&J) has reported more data supporting the efficacy of its intravesical drug release system TAR-200 in ...

Alex Hacopian, MD, highlights how a recent ambispective study demonstrated strong visual acuity outcomes and patient ...

ImmunityBio, Inc. faces stock decline amid fundraising and market selloff. Click to read more on the long-term potential of ...

From computer-using AI agents to autonomous vehicles, we have compiled some of the most powerful real-world AI agents ...

the first randomized controlled trial completed comparing ultrasound energy-based focal ablation versus Robotic Prostatectomy. The study achieved its primary endpoint and demonstrated that the ...

Company confirms Hugo RAS system submission to the U.S. Food and Drug Administration ...